products douglas-laboratories multi-probiotic-4000


By : Douglas Laboratories


Multi-Probiotic 4000 capsules may be a useful dietary supplement for those who wish to support their intestinal microflora with meaningful amounts of beneficial microorganisms.


Each Multi-Probiotic 4000 capsule contains over 4 billion (4000 x 1 million) organisms in the following potencies:

Lactobacillus.acidophilus(DDS-1 )...1.15Billion
L. Rhamnosus ... 1.15 Billion
L. Rhamnosus (Type B, Bifidus)... 775 Million
Bifidobacterium lactis...275 Million
Bifidobacterium longum ... 275 Million
B. Bifidum ... 275 Million
Streptococcus thermophilus... 150 Million

In a base of FOS (fructooligosaccharides), special carbohydrates, enzymes and ulmus fulva


Each Multi-Probiotic 4000 capsule, provided by Douglas Laboratories, contains over four billion beneficial organisms, including representatives of both the lactobacillus and bifidobacterium genera, mixed in a base of prebiotic fructooligosaccharide.

Oral supplements of live, beneficial intestinal micro- organisms for nutritional health and well-being are known as probiotics. Probiotic dietary lactobacilli colonize the intestinal tract, depending on the specific bacterium-to-host affinity. Bacteria are continually in competition for colonization space. The original bacterial colonies have an advantage over transient bacteria. Nevertheless, the composition of the intestinal microflora is dynamic and constantly changing.
If harmful microorganisms proliferate, the equilibrium is disturbed, and it becomes difficult even for indigenous bacteria to maintain their necessary territory to colonize the intestine. Antibiotics tend to kill off both beneficial and harmful bacteria, and thus may also disturb the normal, healthy balance of intestinal microorganisms.
When potent probiotic supplements, such as Multi- Probiotic 4000, are supplied regularly, chances are greatly increased for establishing and maintaining a healthy population of beneficial intestinal microorganisms. Once established, a normal intestinal microflora rich in lactobacilli creates acidic conditions that are unfavorable for the settlement of pathogenic microorganisms.


100 capsules


Adults take 1capsule daily or as directed by physician.

Potential side effects/Safety

No adverse effects have been reported

Keep out of reach of children.


"Show references"

"Hide references"

Cebra JJ. Influences of microbiota on intestinal immune system development. Am J Clin Nutr 1999;69:1046S-1051S.
Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 1999;69:1052S-1057S.
Donnet-Hughes A, Rochat F, Serrant P, Aeschlimann JM, Schiffrin EJ. Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective dose. J Dairy Sci 1999;82:863-9.
Elmer GW, Surawicz CM, McFarland LV. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections [see comments]. Jama 1996;275:870-6.
Gibson GR. Dietary modulation of the human gut microflora using prebiotics. Br J Nutr 1998;80:S209-12.
Goldin BR. Health benefits of probiotics. Br J Nutr 1998;80:S203-7.
acobsen CN, Rosenfeldt Nielsen V, Hayford AE, Moller PL, Michaelsen KF, Paerregaard A, Sandstrom B, Tvede M, Jakobsen M. Screening of probiotic activities of forty-seven strains of lactobacillus spp. by In vitro techniques and evaluation of the colonization ability of five selected strains in humans [In Process Citation]. Appl Environ Microbiol 1999;65:4949-56.
Kirjavainen PV, Ouwehand AC, Isolauri E, Salminen SJ. The ability of probiotic bacteria to bind to human intestinal mucus. FEMS Microbiol Lett 1998;167:185-9.
Pessi T, Sutas Y, Saxelin M, Kallioinen H, Isolauri E. Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria [In Process Citation]. Appl Environ Microbiol 1999;65:4725-8.
Tejada-Simon MV, Lee JH, Ustunol Z, Pestka JJ. Ingestion of yogurt containing Lactobacillus acidophilus and Bifidobacterium to potentiate immunoglobulin A responses to cholera toxin in mice. J Dairy Sci 1999;82:649-60.
Venturi A, Gionchetti P, Rizzello F, Johansson R, Zucconi E, Brigidi P, Matteuzzi D, Campieri M. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther 1999;13:1103-8.
Wang X, Ma G, Zheng B, Tian H. [Effects of SL-probiotic preparation on the body weight and phagocytosis of white mice]. Wei Sheng Wu Hsueh Pao 1995;35:455-9.

Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. © 2015 NDAssist Inc. and/or its affiliates. All rights reserved.